Authors: Tomas Gabriel Bas, Jorge Niosi
Addresses: Center of Innovation and Technology, UAI, World Bank Research, University Adolfo Ibanez, Av. Presidente Errazuriz 3485, Las Condes, Santiago, Chile. ' Department of Management and Technology, Universite du Quebec a Montreal, P.O. Box 8888, Station Centre-Ville, Montreal, H3C 3P8, Canada
Abstract: There are over 5000 Specialised Biotechnology Firms (SBFs) in the world, out of which at least 1500 are in the USA, 400 in Canada, and a similar number in the UK. Within this group of SBFs rapid growth is concentrated in some 10% of the firms. This paper compares the growth patterns of SBFs in the USA and the UK, and with the previous results for Canada. These three countries represent nearly 50% of SBFs in the world. By combining several different databases, the paper reveals the determining factors of SBF growth in the two leading countries. Using correlation and logistic regressions for each country, we found that five factors (patents, the targeting of human health products and processes, the support of venture capital, R&D and marketing corporate alliances, and the search for world markets) explain most of the growth of these firms.
Keywords: specialised biotechnology firms; SBFs; unequal growth; competence theory of the firm; resource-based theory of the firm; patents; human health; venture capital; marketing alliances; USA; UK; Canada; United Kingdom; United States; R&D; research and development.
International Journal of Biotechnology, 2007 Vol.9 No.1, pp.87 - 100
Published online: 26 Jan 2007 *Full-text access for editors Access for subscribers Purchase this article Comment on this article